Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Intellikine and PKD Foundation collaborate on treatment of polycystic kidney disease

Feb. 14, 2011

Botulinum neurotoxin type A is efficacious in urological disorders

Feb. 14, 2011

Futura Medical and Ansell enter commercialization agreement for PET-500

Feb. 11, 2011

EMA approves sublingual sildenafil formulation X-Excite for erectile dysfunction

Feb. 3, 2011

Rockwell Medical secures participation of two U.S. dialysis companies in phase III SFP trials

Feb. 2, 2011

Auspex Pharma patents new beta3-adrenoceptor modulators

Jan. 21, 2011

Ono Pharma claims new agents for urinary incontinence

Jan. 20, 2011

FP-1097 is effective in phase II trial in female incontinence and overactive bladder

Jan. 14, 2011

Apricus Biosciences grants Bracco rights to market Vitaros in Italy

Jan. 3, 2011

Phase I/II data reported on OMS-201 in patients undergoing ureteroscopy

Dec. 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026